During the past decade, The Regents of The University of Michigan conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Regents of The University of Michigan" #1 sponsor was "Novartis Pharmaceuticals" with 2 trials, followed by "Duke University" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Shire" with 1 trials sponsored and "University of Iowa" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Regents of The University of Michigan" #1 collaborator was "University of Michigan" with 2 trials as a collaborator, "Allina Health System" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "The Regents of The University of Michigan" are "Adenoviral Conjunctivitis" (1 trials), "Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma" (1 trials), "Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies" (1 trials), "Depression" (1 trials) and "Gastroenteropancreatic Neuroendocrine Tumor" (1 trials). Many other conditions were trialed in "The Regents of The University of Michigan" in a lesser frequency.

Most popular intervention types in "The Regents of The University of Michigan" are "Drug" (4 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Collaborations in Health (COACH)" (1 trials), "Everolimus" (1 trials), "HDM201" (1 trials), "LCL161" (1 trials) and "LEE011" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Regents of The University of Michigan" are 7 trials for "All" genders.

Currently, there are NaN active trials in "The Regents of The University of Michigan". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in The Regents of The University of Michigan, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Regents of The University of Michigan, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".